Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
H
Haddish-Berhane, Nahor
Janssen Research & Development LLC
024
:
The Drug-Drug Interaction Effect of Steady State Rifampin Exposure on Single Dose Pharmacokinetics of Lazertinib
Nahor Haddish-Berhane
Favorite
107
:
Pharmacokinetic & Immunogenicity Results from the China Cohort of the MAJESTEC-1 Study of Teclistamab for Relapsed/refractory Multiple Myeloma
Nahor Haddish-Berhane
Favorite
Hanley, Michael
Takeda Development Center Americas, Inc.
070
:
Population Pharmacokinetic & Exposure-Response Analyses for the Phase 3 PhALLCON Study of Ponatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Michael Hanley
Favorite
Hong, Soyeon
Department of Pharmacy, Seoul National University Bundang Hospital
130
:
Clinical Outcomes of Carfilzomib-based Chemotherapy by Relative Dose Intensity in Patients with Relapsed or Refractory Multiple Myeloma
Soyeon Hong
Favorite
Hooper, Levi
Univ of Michigan
163
:
GLP-1-Induced Delays in GI Motility & Their Effects on Co-Administered Drug Absorption: A PBPK Analysis
Levi Hooper
Favorite
Huntjens, Dymphy
Priothera SAS
033
:
Clinical Assessment of Mocravimod as a Victim of Drug-Drug Interactions via CYP3A Metabolism & Transporters
Dymphy Huntjens
Favorite
